Adverse Event reporting information can be found in footer
Request a Meeting
The Principal York
Station Road, York
North Yorkshire
YO24 1AA
One day meeting discussing the decision points and dilemmas of managing IBD.
Following the journey of two patients; Ulcerative Colitis and Crohn’s Disease.
The Beatles sang about a “Day in the Life”, we would like to share a snapshot of the life of two IBD patients in a day.
We are delighted to invite you to an exciting educational event looking at the course of two patients with IBD. Ferring Pharmaceuticals, the sponsors, have given us free-rein to bring a talented group of speakers to you. They will address key topics and treatment decisions as we follow the journey of two patients; one with ulcerative colitis and one with Crohn’s disease, through diagnosis, assessment, treatment and management of complications.
The day is designed to share experience as well as how to apply current evidence in a practical way, to help you in your own clinical work.
We hope you enjoy it,
Commissioned and sponsored by Ferring Pharmaceuticals. Ferring Pharmaceuticals has not been involved in the creation & development of the educational content for this meeting.
Richard Beable
Consultant Radiologist - Queen Alexandra Hospital
Ashley Bond
Gastroenterology Registrar - Salford Royal NHS Foundation Trust
Daniel Gaya
Consultant Gastroenterologist - Glasgow Royal Infirmary
Nyree Griffin
Lead Gastrointestinal Consultant Radiologist - Guy's and St Thomas' NHS Foundation Trust
Melissa Hale
Consultant Gastroenterologist - Sheffield Teaching Hospitals NHS Trust
Phillip Harrison
London Bridge Hospital
Emma Johnston
Gastroenterology Registrar - Queen Elizabeth Hospital
Joel Mawdsley
Consultant Gastroenterologist - Guy's and St Thomas' NHS Foundation Trust
Sara McCartney
Consultant Gastroenterologist - University College London Hospital
Marco Novelli
Lead Gastrointestinal Histopathologist - University College London Hospital
Paul O'Toole
Consultant Endoscopist - Royal Liverpool University Hospital
Jonathan Rhodes
Emeritus Professor of Medicine - Royal Liverpool University Hospital
Melissa Smith
Consultant Gastroenterologist - Brighton and Sussex University Trust
Janindra Warusavitarne
Colorectal Surgeon - St Mark's Hospital
Vice Chair ‐ Clinical Advisor’s Committee of Crohn’s and Colitis UK
After graduating from University of Birmingham (MBChB 1985) and obtaining MRCP (UK) in 1988. Chris was awarded MD by University of Leicester, in 1993, for the study of the epidemiology of inflammatory bowel disease in South Asian migrants.
Chris undertook a BDF (now CORE) funded research fellowship at Harvard for 2 years, with Prof Rick Blumberg, studying the mucosal immunology of inflammatory bowel disease.
After this fellowship, Chris was appointed to the post of Senior Lecturer, then Reader, in the Department of Medicine at University of Bristol. He was clinical lead for gastroenterology, and later for inflammatory bowel diseases, at University Hospital Bristol NHS Foundation Trust.
In 2007, Chris was appointed to the chair of gastroenterology in Bristol. In 2011, he was appointed Professor of Gastroenterology at University of Liverpool. He has a major research interest in the study of volatile organic compounds (VOCs) for disease diagnosis, funded by Wellcome Trust and Cancer Research UK.
He has published >125 original papers and >45 reviews in peer-reviewed manuscripts, he has edited 5 textbooks and contributed to many others.
He is Vice Chair of the Clinical Advisor’s Committee of Crohn’s and Colitis UK (NACC) and recent past-chair of the IBD Committee of the BSG.
Professor of Gastroenterology – Kings College London
Professor Jeremy Sanderson is Professor of Gastroenterology at Kings College London and Consultant Gastroenterologist at Guy’s & St. Thomas’ Hospitals NHS Foundation Trust (GSTT).
He was appointed consultant in 1995 having trained in London and in Melbourne, Australia. Since his appointment as a consultant, he has steadily built up a comprehensive tertiary IBD unit at GSTT into one of the largest in the UK. The unit has a strong focus on personalised IBD medicine with specific emphasis on optimal use of immunosuppression and biologics, and a unique expertise in oral Crohn’s disease.
His research interests include the genetics, pharmacogenetics, immunology and microbiology of IBD and the pathogenesis and treatment of oral Crohn’s / orofacial granulomatosis. He has published extensively in these areas and is a regular lecturer and teacher on aspects of IBD nationally and internationally.
He is currently Clinical Director of Gastrointestinal Medicine and Surgery at GSTT, a role far removed from the pleasures of IBD research and treatment. Professor Sanderson hails from near York and is rumoured to like trains. He has never denied this…
Vice Chair ‐ Clinical Advisor’s Committee of Crohn’s and Colitis UK
After graduating from University of Birmingham (MBChB 1985) and obtaining MRCP (UK) in 1988. Chris was awarded MD by University of Leicester, in 1993, for the study of the epidemiology of inflammatory bowel disease in South Asian migrants.
Chris undertook a BDF (now CORE) funded research fellowship at Harvard for 2 years, with Prof Rick Blumberg, studying the mucosal immunology of inflammatory bowel disease.
After this fellowship, Chris was appointed to the post of Senior Lecturer, then Reader, in the Department of Medicine at University of Bristol. He was clinical lead for gastroenterology, and later for inflammatory bowel diseases, at University Hospital Bristol NHS Foundation Trust.
In 2007, Chris was appointed to the chair of gastroenterology in Bristol. In 2011, he was appointed Professor of Gastroenterology at University of Liverpool. He has a major research interest in the study of volatile organic compounds (VOCs) for disease diagnosis, funded by Wellcome Trust and Cancer Research UK.
He has published >125 original papers and >45 reviews in peer-reviewed manuscripts, he has edited 5 textbooks and contributed to many others.
He is Vice Chair of the Clinical Advisor’s Committee of Crohn’s and Colitis UK (NACC) and recent past-chair of the IBD Committee of the BSG.
Professor of Gastroenterology – Kings College London
Professor Jeremy Sanderson is Professor of Gastroenterology at Kings College London and Consultant Gastroenterologist at Guy’s & St. Thomas’ Hospitals NHS Foundation Trust (GSTT).
He was appointed consultant in 1995 having trained in London and in Melbourne, Australia. Since his appointment as a consultant, he has steadily built up a comprehensive tertiary IBD unit at GSTT into one of the largest in the UK. The unit has a strong focus on personalised IBD medicine with specific emphasis on optimal use of immunosuppression and biologics, and a unique expertise in oral Crohn’s disease.
His research interests include the genetics, pharmacogenetics, immunology and microbiology of IBD and the pathogenesis and treatment of oral Crohn’s / orofacial granulomatosis. He has published extensively in these areas and is a regular lecturer and teacher on aspects of IBD nationally and internationally.
He is currently Clinical Director of Gastrointestinal Medicine and Surgery at GSTT, a role far removed from the pleasures of IBD research and treatment. Professor Sanderson hails from near York and is rumoured to like trains. He has never denied this…
Job Code: UK-GAS-2000011 - Date of preparation: July 2022